Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 18/20 | 1.00 |
| ▸ | ABL1 | P00519 | 3/20 | 0.60 |
| ▸ | ABL2 | P42684 | 2/20 | 0.60 |
| ▸ | ERBB2 | P04626 | 3/20 | 0.58 |
| ▸ | PTK6 | Q13882 | 1/20 | 0.58 |
| ▸ | FBP1 | P09467 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | GAK | O14976 | 1/20 | 0.53 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CDK1 | P06493 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | SRC | P12931 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | EPHB2 | P29323 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7222290 | 0.82 | EGFR (1.00) | EGFRABL1ABL2FBP1ABCG2 | |
| Hydrochloric Acid SCHEMBL7217999 | 0.81 | EGFR (0.97) | EGFRABL1ABL2FBP1ABCG2 | |
| SCHEMBL3663489 | 0.80 | EGFR (1.00) | EGFRABL1ERBB2FBP1KDM4E | |
| Diethylamine SCHEMBL7221527 | 0.79 | EGFR (0.65) | EGFRERBB2PTK6FBP1KDR | |
| SCHEMBL7221523 | 0.77 | EGFR (0.62) | EGFRERBB2PTK6MAPTKDR | |
| Hydrochloric Acid SCHEMBL7221286 | 0.76 | EGFR (0.61) | EGFRERBB2PTK6MAPTKDR | |
| SCHEMBL3000564 | 0.75 | EGFR (0.70) | EGFRERBB2SRCERBB4 | |
| SCHEMBL2461158 | 0.75 | EGFR (1.00) | EGFRABL1ABL2KDR | |
| SCHEMBL2462868 | 0.73 | EGFR (1.00) | EGFRABL1ABL2KDRMAPK14 | |
| SCHEMBL6882267 | 0.73 | TNNI3K (0.74) | EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6596726-B1 | Method of inhibiting epidermal growth factor by treating, with an effective inhibiting amount, a mammal, in need thereof inhibit the epidermal growth factor receptor and related receptors and, in particular, their tyrosine kinase enzyme | WARNER LAMBERT COMPANY | 2003-07-22 | — | — | US | disclosed |
| EP-0741711-A1 | TRICYCLIC COMPOUNDS CAPABLE OF INHIBITING TYROSINE KINASES OF THE EPIDERMAL GROWTH FACTOR RECEPTOR FAMILY | WARNER-LAMBERT COMPANY (US) | 1996-11-13 | — | — | EP | disclosed |
| WO-1995019970-A1 | TRICYCLIC COMPOUNDS CAPABLE OF INHIBITING TYROSINE KINASES OF THE EPIDERMAL GROWTH FACTOR RECEPTOR FAMILY | WARNER-LAMBERT COMPANY (US) | 1995-07-27 | — | — | WO | disclosed |